Latest Intel chips beat Apple’s M5 in multi-core scores – for maybe two days

Independent benchmarks by Wired show Intel's new Core Ultra Series 3 briefly outscored Apple's M5 in two tests: the Core Ultra X9 388H posted a Cinebench R24 multi-core score of 1285 versus the M5's 922 and 3DMark Steel Nomad Light of 5883 versus 5077. Tests were run on an MSI Prestige 14 Flip (X7 358H) and a 16-inch Lenovo IdeaPad reference unit (X9 388H); however the Intel gains are likely short-lived as Intel trails Apple’s M4 Pro in other comparisons and the upcoming M5 Pro/Max MacBook Pro models are expected to substantially outperform Intel's chips.

Analysis

Market structure: Intel’s short-lived benchmark wins create a near-term beneficiary (INTC) for PR-driven OEM momentum but do not alter longer-term economics: AAPL (and its suppliers/foundry partners) retain structural pricing power from vertical integration and software advantage. Expect marginal share shifts in Windows laptop SKUs over 1–3 quarters if OEMs price aggressively; sustained share gains for Intel would require consistent multi-generation parity, not single-benchmark headlines.

Risk assessment: Immediate (days) risk is headline-driven volatility around the MacBook M5 Pro/Max launch; short-term (weeks–months) risk includes disappointing real-world M5 Pro/Max benchmarks or supply shortages from TSMC; long-term (quarters) tail risks include regulatory action (antitrust scrutiny of platform dominance) or Intel fab execution failures. Hidden dependencies: thermal envelope and software optimization will determine consumer uptake more than raw Cinebench numbers.

Trade implications: Tactical window (0–30 days) favors capturing momentum in INTC but exiting into the Apple launch; medium-term (3–9 months) favors AAPL outperformance as M5 Pro/Max likely reasserts dominance. Options: use defined-risk call spreads on AAPL around launch (30–60 day expiries) and buy 60-day puts on INTC or sell covered calls to monetize near-term pops. Consider modest exposure to AMZN (0.5–1%) to capture retail/fulfillment upside from any Mac sales spike.

Contrarian angles: The market may overvalue single-benchmark wins—this is likely a transient marketing victory and not a durable node shift; a >10–15% rally in INTC on this news would be a mean-reversion candidate. Historical parallel: Apple’s M1 cycle shows early skepticism followed by durable share gains—if M5 Pro/Max meets extrapolated gains, AAPL could re-rate over 3–12 months. Unintended consequence: Intel may pursue aggressive OEM pricing, compressing margins across PC supply chains and creating downstream winners (low-cost OEMs) and losers (Intel margins).

Key Decisions for Investors

• Establish a tactical 1.5–2.5% long position in INTC to capture short-term PR momentum, with a hard profit target of +15% or a time stop of 14 days post-Apple launch; if price moves >8% intraday, reduce position by 50%.
• Establish a 3–5% long position in AAPL on a 3–9 month view around M5 Pro/Max launch; add another 1–2% if independent Geekbench/real-world GPU scores exceed M4 Pro by >25% and channel sell-through in week-1 exceeds 75% of inventory.
• Implement an AAPL 30–60 day call spread (~debit-limited) sized for 1–2% notional to opportunistically capture post-launch upside; strike selection should target breakeven ~+4–6% above current price and max loss limited to premium paid.
• Hedge the portfolio with 60-day INTC puts sized to cover 50% of the INTC long exposure (or sell covered calls against existing INTC holdings at 10–15% OTM expiries 30–45 days), to protect against mean reversion if M5 Pro/Max outperforms.